Introduction
============

As is universally acknowledged, gastric cancer is a critical illness threatening human health and existence. According to the statistics, gastric cancer ranks the fourth and the third in morbidity and mortality among all cancers, respectively.[@b1-ott-9-6801] The year 2012 had witnessed 951,600 new gastric cancer cases and 723,100 deaths, with the mortality rate being as high as 76%, accounting for 8% of the cancer cases and 10% of cancer deaths, respectively.[@b2-ott-9-6801] Gastric cancer, distal gastric cancer in particular, is associated with a low 5-year survival rate, and its morbidity and mortality are in continuous growth in most developing countries.[@b3-ott-9-6801] Most of the patients with gastric cancer are diagnosed at an advanced stage at the first time they consult a doctor. As a consequence, early detection is particularly important in the diagnosis of gastric cancer.[@b4-ott-9-6801] Affected by many factors, gastric cancer has a complex genesis and development process. Currently, the relationship between single nucleotide polymorphisms (SNPs) and gastric cancer remains unclear, but it may help to explain the genetic susceptibility of patients with risk of gastric cancer.

Matrix metalloproteinase (MMP) is a class of Zn^2+^- and Ca^2+^-dependent endogenous proteolytic enzyme that is also a membrane-spanning protein and can degrade the extracellular matrix and the basement membrane under physical conditions.[@b5-ott-9-6801] It is extensively considered that MMPs play an important role in promoting the growth, invasion, and metastasis of tumor cells.[@b6-ott-9-6801] TIMP is a natural inhibitor of MMPs when it combines with them. Under normal conditions, MMPs and TIMPs maintain a relative state of equilibrium in vivo and sustain the integrity of the extracellular matrix and the basement membrane, so that the role of inhibiting the invasion and metastasis of tumor cells can be achieved. It has been shown that MMP-2 and TIMP-2 play a vital role in the invasion and metastasis of gastric cancer.[@b7-ott-9-6801],[@b8-ott-9-6801] Genetic polymorphism, especially SNP, is the most common genetic variation in human beings.[@b9-ott-9-6801]

As indicated in some studies, TIMP-2-418G/C and TIMP2-303G/A, which locate in the promoter and third exon region of the TIMP-2 gene polymorphism, respectively, may alter their own gene transcription activity or spatial conformation and influence their expression in the body, thereby affecting the occurrence of tumor.[@b10-ott-9-6801]--[@b12-ott-9-6801] It has been reported that these two polymorphisms are associated with the risk of lung cancer, breast cancer, head and neck cancer, endometrial cancer, colon cancer and other malignant tumors; however, the relationship between the two SNPs and the risk of gastric cancer is still unknown.[@b13-ott-9-6801]--[@b15-ott-9-6801] So far, no meta-analysis has been conducted to investigate the correlation between them, which can account for the reason why a meta-analysis should be performed to assess the association between TIMP-2-418G/C and TIMP-2-303G/A polymorphisms and the susceptibility to gastric cancer.

Materials and methods
=====================

Search strategy
---------------

Two independent investigators systematically searched PubMed, Embase, CNKI and Wanfang databases for studies published before April 20, 2016. The following keywords were used: "TIMP-2" or "tissue inhibitor matrix metalloproteinase-2", "polymorphisms" or "genetic polymorphisms" or "mutation" or "variation" or "genotype" or "single nucleotide" and "stomach neoplasm" or "gastric neoplasm" or "stomach cancer" or "gastric cancer" or "cancer of the stomach". No limitations were placed on language. Only published studies with full texts were enrolled, and meeting or conference abstracts were not covered.

Inclusion and exclusion criteria
--------------------------------

Eligible studies should meet the following criteria: 1) studies that scrutinized the association of TIMP-2-418G/C, TIMP-2-303G/A polymorphisms and the risk of gastric cancer that has been confirmed by histopathological examinations; 2) research methodology based on an unrelated case--control design; and 3) detailed genotype data for estimating odds ratio (OR) and 95% confidence interval (CI). Exclusion criteria were: 1) duplication of earlier publications; 2) comments, reviews and editorials; 3) family-based studies of pedigrees; and 4) studies with no detailed genotype data.

Data extraction
---------------

Two investigators independently evaluated and extracted the data. For each study, the following information was extracted: first author, year of publication, ethnicity, genotyping method, Hardy--Weinberg equilibrium (HWE) and the quality assessment of the studies. Any controversy on the baseline information was consulted with a third author. Two authors checked the extracted data and reached an agreement on the obtained data. If there was any objection, they would review the raw data of the included studies and have a discussion to reach an agreement. If a disagreement still existed, the third investigator would be involved to verdict the dissent ([Table 1](#t1-ott-9-6801){ref-type="table"}).

Quality assessment
------------------

Two investigators independently evaluated and scored the qualities of the included studies in accordance with the Newcastle--Ottawa Quality Assessment Scale, which is a star-rating system. The quality of the studies was evaluated by examining three items: selection of case and controls, comparability of groups and ascertainment of exposure. Nine stars are defined as the full score; five to nine stars are usually considered to be a high methodological quality while zero to four stars are considered to be a poor quality. The quality of all enrolled studies is shown in [Table 1](#t1-ott-9-6801){ref-type="table"}.

Statistical analysis
--------------------

We organized and reported our meta-analysis on the basis of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.[@b16-ott-9-6801] HWE was assessed for each study by chi-squared test in the control group, and *P*\<0.05 was considered a significant departure from HWE. OR and 95% CIs were calculated to evaluate the correlation of TIMP-2-418/303 SNPs and the susceptibility to gastric cancer. Heterogeneity was assessed by *Q* statistic (significance level of *P*\<0.05) and *I*^2^ statistic (\>50% as evidence of significant inconsistency).[@b17-ott-9-6801] A fixed-effects model (if *P*-value \>0.05) or a random-effects model (if *P*-value \<0.05) was used for pooling the results.[@b18-ott-9-6801] Sensitivity analysis was also implemented to assess the effect of each study on the combined ORs by deleting each study in each turn. Besides, subgroup analyses were stratified by ethnicity. Publication bias was checked by Begg's funnel plots and Egger's regression test.[@b19-ott-9-6801],[@b20-ott-9-6801] An asymmetric plot and the *P*-value of Egger's test \<0.05 was considered a significant publication bias. All statistical analyses were implemented using Stata 12.0 software (StataCorp LP, College Station, TX, USA). All *P*-values were two sided, and the statistical significance level was considered as *P*-value \<0.05 for this meta-analysis.

Results
=======

Characteristics of studies
--------------------------

In total, 85 studies were obtained from PubMed, Embase, CNKI and Wanfang databases (PubMed: 32; Embase: 48; CNKI: 2; Wanfang: 3). The literature selection process is shown in [Figure 1](#f1-ott-9-6801){ref-type="fig"}. All searched articles were thoroughly reviewed by reading the titles and abstracts, and the full texts for the potentially relevant research articles were further inspected for their adequacy for this meta-analysis. We included only case--control studies reporting the frequency of all five genotypes, and studies investigating the levels of TIMP-2 mRNA or protein expression or relevant review articles were excluded from this study.

Evaluation of heterogeneity
---------------------------

To test the heterogeneity among the selected publications, *Q*-test and *I*^2^ statistics were employed. Heterogeneity was observed in all the genetic models, ie, allele (C vs G or A vs G), homozygous (CC vs GG or AA vs GG), heterozygous (GC vs GG or GA vs GG), dominant (CC + GC vs GG or AA + GA vs GG) and recessive (CC vs GG + GC or AA vs GG + GA). As a consequence, random-effects model was mostly applied to analyze the data for TIMP-2-418G/C, while fixed-effects model was applied to analyze the TIMP-2-303G/A data ([Table 2](#t2-ott-9-6801){ref-type="table"}).

Publication bias
----------------

Begg's funnel plot and Egger's test were implemented to assess the publication bias for TIMP-2-418G/C and gastric cancer susceptibility. The funnel plots failed to reveal any obvious asymmetry in all genotypes in the overall population. Neither Begg's test nor Egger's test showed statistical evidence for publication bias in our meta-analysis (*P*\>0.05). Neither Begg's funnel plot nor Egger's test was performed to assess the association between TIMP-2-303G/A and gastric cancer susceptibility owing to the limited number of included studies.

Sensitivity analysis
--------------------

To assess the stability of our meta-analysis results, we implemented sensitivity analysis to define whether the inclusion criteria of this meta-analysis influenced the results. Sensitivity analysis was performed to examine the influence set by the individual study on the pooled ORs for TIMP-2-418G/C and TIMP-2-303G/A by deleting each study once in every genetic model. We observed no significant difference after the omission of any study for all the five models, implying that our results are statistically reliable.

Association between TIMP-2-418G/C polymorphism and gastric cancer susceptibility
--------------------------------------------------------------------------------

The association between TIMP-2-418G/C polymorphism and the risk of gastric cancer was analyzed in six independent studies. For the heterogeneity, this result should be treated with caution. Random-effects model was used in the allele model, homozygote model, dominant model and recessive model due to the presence of heterogeneity, and fixed-effects model was used in the heterozygote model. Overall, significant association was not identified in any genetic model (C vs G: OR =1.131, 95% CI 0.840--1.521, *P*~H~=0.417; CC vs GG: OR =1.576, 95% CI 0.602--4.127, *P*~H~=0.355; GC vs GG: OR =1.038, 95% CI 0.875--1.231, *P*~H~=0.670; GC + CC vs GG: OR =1.098, 95% CI 0.853--1.414, *P*~H~=0.467; CC vs GC + GG: OR =1.543, 95% CI 0.620--3.842, *P*~H~=0.351; [Table 3](#t3-ott-9-6801){ref-type="table"}).

Association between TIMP-2-303G/A polymorphism and gastric cancer susceptibility
--------------------------------------------------------------------------------

No significant heterogeneity was identified by *Q*-test and *I*^2^ statistic in any of the genetic models; therefore, fixed-effects model was used in all the models. A significant increased risk of gastric cancer was observed in homozygote comparison (AA vs GG: OR =0.498, 95% CI 0.332--0.748, *P*~H~=0.001; [Figure 2](#f2-ott-9-6801){ref-type="fig"}), recessive comparison (AA vs GA + GG: OR =0.499, 95% CI 0.335--0.742, *P*~H~=0.001; [Figure 3](#f3-ott-9-6801){ref-type="fig"}) and allele comparison (A vs G: OR =0.799, 95% CI 0.683--0.934, *P*~H~=0.005; [Figure 4](#f4-ott-9-6801){ref-type="fig"}). No significant association was found in heterozygote comparison (GA vs GG: OR =0.926, 95% CI 0.757--1.132, *P*~H~=0.453) or dominant comparison (GA + AA vs GG: OR =0.844, 95% CI 0.697--1.023, *P*~H~=0.083; [Table 3](#t3-ott-9-6801){ref-type="table"}).

Next, subgroup analysis was conducted according to ethnicity. In Asians, a significant increased risk of gastric cancer was observed in homozygote comparison (AA vs GG: OR =0.476, 95% CI 0.314--0.772, *P*~H~=0.000), recessive comparison (AA vs GA + GG: OR =0.476, 95% CI 0.314--0.722, *P*~H~=0.000) and allele comparison (A vs G: OR =0.811, 95% CI 0.687--0.957, *P*~H~=0.013). In addition, no significant association was found in heterozygote comparison (GA vs GG: OR =1.000, 95% CI 0.803--1.244, *P*~H~=0.997) or dominant comparison (GA + AA vs GG: OR =0.884, 95% CI 0.719--1.088, *P*~H~=0.899). As for Caucasian populations, no obvious association was found between TIMP-2-303G/A polymorphism and the risk of gastric cancer in all the genetic models ([Table 3](#t3-ott-9-6801){ref-type="table"}).

Discussion
==========

In this meta-analysis, eight qualified case--control studies including 1,265 cases and 1,671 controls for TIMP-2-418G/C and four studies including 947 cases and 946 controls for TIMP-2-303G/A were analyzed. Consistent with the previous meta-analyses focused on TIMP-2-418G/C polymorphism and cancer risk, no evidence was found for the association between TIMP-2-418G/C polymorphism and gastric cancer susceptibility in any genetic models, and similar results were discovered in the subgroup analysis by ethnicity. On the other hand, TIMP-2-303G/A polymorphism had a significant association with increased risk of gastric cancer in homozygote recessive and allele comparisons, and similar results were observed in the subgroups of Asian populations. However, this finding should be interpreted with caution for limited sample heterogeneity.

TIMP-2 genes are located in human chromosome 17q23--17q25, which participate in the regulation of MMP2 activity and have a promoting effect on cell growth.[@b21-ott-9-6801],[@b22-ott-9-6801] TIMP-2 gene is a specific tissue inhibiting factor for MMP2 gene, which could combine with MMP2 enzymes and active enzyme in a ratio of 1:1 and then cause inactivation of the latter. The balance between MMP2 and TIMP-2 has important significance in maintaining the integrity of the basement membrane and the normal function of MMP-2.

TIMP-2-418G/C polymorphism could destroy the combination of the transcription factor Spl, which may cause a decline in genetic transcription activity.[@b11-ott-9-6801] We have collected the studies on the association of TIMP-2-418G/C polymorphism with the risk of gastric cancer, but the results were not quite similar. Reports by Yang et al[@b23-ott-9-6801] and Zhang et al[@b24-ott-9-6801] showed that TIMP-2-418G/C polymorphism had an increased risk of developing gastric cancer and might be correlated with gastric cancer susceptibility.[@b23-ott-9-6801] But in the mean time, reports from Wu et al,[@b25-ott-9-6801] Chen et al[@b26-ott-9-6801] and Sun[@b27-ott-9-6801] showed that no association had been found between -418G/C polymorphism and the risk of gastric cancer. Kubben et al[@b28-ott-9-6801] did not report the relationship between --418G/C polymorphism and gastric cancer risk. Our results indicated that -418G/C SNP had no association with the risk of gastric cancer in any genetic models. During the subgroup analysis, we found that ethnicity had no effect on the association between TIMP-2-418G/C polymorphism and gastric cancer in any of the genetic models, suggesting -418G/C SNP was not associated with gastric cancer in either Asian or Caucasian. As for sensitivity analysis of TIMP-2-418G/C, although the included studies differed from one another in various aspects, the association could be driven by none of the single study.

TIMP-2-303G/A is located in the third exon of TIMP-2 gene, which belongs to synonymous mutation. Although synonymous mutation does not alter coded amino acid, nucleotide sequence was changed, which might have an influence on posttranscriptional processing, cut-grafting order of signal and important bases in promoter region. The -303G/A locus polymorphism of TIMP-2 may destroy the combination of transcription factor Spl, which may decrease the transcriptional activity of genes.[@b29-ott-9-6801] Zhang et al's[@b24-ott-9-6801] and Lin et al's[@b30-ott-9-6801] works proved that TIMP-2-303G/A variants might be correlated with gastric cancer susceptibility, while no significant correlation was observed in Alakus et al's[@b12-ott-9-6801] and Kubben et al's[@b28-ott-9-6801] works. This work proved that TIMP-2-303G/A was correlated with gastric cancer susceptibility in homozygote recessive and allele models. For TIMP-2-303G/A, when we focused on Asian population through the subgroup analysis, positive association was observed in all the genetic models, while the study conducted in Caucasians showed no significant association in any of the genetic models. This could be explained by factors such as the different life styles and ethnicity. As to sensitivity analysis of TIMP-2-303G/A, the association could be driven by none of the single study as well.

Our meta-analysis has some advantages. First, this is the first meta-analysis focused on the association between TIMP-2 polymorphisms and the susceptibility to gastric cancer compared with the former meta-analyses about TIMP-2 polymorphism. Second, another TIMP-2 polymorphism of TIMP-2-303G/A was also explored. Third, there was no obvious evidence of publication bias through qualitative funnel plot and quantitative Egger linear regression, which indicated that our results are statistically robust. Fourth, no limitation was made in the literature search, thus selection bias was well controlled. In spite of the significant findings from our current analysis, we still have to acknowledge some of the limitations of this analysis. First of all, the number of included studies for TIMP-2-303G/A polymorphism limited further analysis due to the shortage of original studies. In addition, one study did not conform to HWE expectations for TIMP-2- 418G/C. Finally, lacking individual data of environmental exposure limited our further studies of gene--environment interactions.

Conclusion
==========

This meta-analysis suggested that TIMP-2-418G/C polymorphism might not be associated with the susceptibility to the risk of gastric cancer in the overall population, while TIMP-2-303G/A polymorphism had a significant association with increased risk of gastric cancer, especially in Asians. However, there were inadequate data to completely verify the association of TIMP-2-303G/A polymorphism and the risk of gastric cancer. Taking into account the limitations mentioned earlier, it is necessary to implement more elaborately designed studies with a larger sample size in the future.
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###### 

Main characteristics of all studies included in the meta-analysis

  Study ID                         Year   Ethnicity   Case   Control   *P* for HWE   Quality                      
  -------------------------------- ------ ----------- ------ --------- ------------- --------- ----- ---- ------- ---
  TIMP-2-418G/C                                                                                                   
   Kubben et al[@b28-ott-9-6801]   2006   Caucasian   68     10        1             133       35    1    0.999   6
   Yang et al[@b23-ott-9-6801]     2007   China       121    68        17            141       61    4    0.674   6
   Wu et al[@b25-ott-9-6801]       2007   China       196    38        6             223       47    13   0.003   7
   Sun[@b27-ott-9-6801]            2009   China       186    66        5             431       176   17   0.982   7
   Chen et al[@b26-ott-9-6801]     2014   China       217    81        6             213       84    5    0.598   7
   Zhang et al[@b24-ott-9-6801]    2015   China       149    84        21            171       74    5    0.649   7
  TIMP-2-303G/A                                                                                                   
   Kubben et al[@b28-ott-9-6801]   2006   Caucasian   68     10        1             133       35    1    0.721   6
   Alakus et al[@b12-ott-9-6801]   2010   Caucasian   107    27        1             42        16    0    0.476   6
   Lin et al[@b30-ott-9-6801]      2011   China       267    187       26            243       169   46   0.130   7
   Zhang et al[@b24-ott-9-6801]    2015   China       144    98        12            133       90    27   0.649   7

**Abbreviation:** HWE, Hardy--Weinberg equilibrium.

###### 

Genotypic distribution of TIMP-2-418G/C gene polymorphism

  Comparisons      Heterogeneity analysis   Model for the meta-analysis   
  ---------------- ------------------------ ----------------------------- --------
  TIMP-2-418G/C                                                           
   C vs G          0.003                    72.3                          Random
   CC vs GG        0.002                    75.8                          Random
   GC vs GG        0.504                    0.0                           Fixed
   CC + GC vs GG   0.067                    51.6                          Random
   CC vs GG + GC   0.005                    73.4                          Random
  TIMP-2-303G/A                                                           
   A vs G          0.934                    0.0                           Fixed
   AA vs GG        0.683                    0.0                           Fixed
   GA vs GG        0.391                    0.2                           Fixed
   AA + GA vs GG   0.710                    0.0                           Fixed
   AA vs GG + GA   0.632                    0.0                           Fixed

###### 

Statistics to test publication bias and heterogeneity in the meta-analysis

                      N   OR                  *P*~H~   OR                  *P*~H~   OR                  *P*~H~   OR                   *P*~H~   OR                   *P*~H~
  ------------------- --- ------------------- -------- ------------------- -------- ------------------- -------- -------------------- -------- -------------------- --------
  **TIMP-2-418G/C**       **C/G**                      **CC/GG**                    **GC/GG**                    **CC** + **GC/GG**            **CC/CG** + **GG**   
  Overall             6   1.13 (0.84--1.52)   0.417    1.58 (0.60--4.13)   0.355    1.04 (0.88--1.23)   0.670    1.10 (0.85--1.41)    0.467    1.54 (0.62--3.84)    0.351
  Asian               5   1.12 (0.83--1.52)   0.458    1.58 (0.60--4.13)   0.355    1.04 (0.87--1.23)   0.692    1.09 (0.84--1.42)    0.510    1.54 (0.62--3.84)    0.351
  **TIMP-2-303G/A**       **A/G**                      **AA/GG**                    **GA/GG**                    **AA** + **GA/GG**            **AA/GG** + **GA**   
  Overall             4   0.80 (0.68--0.93)   0.005    0.50 (0.33--0.75)   0.001    0.93 (0.76--1.13)   0.453    0.84 (0.70--1.02)    0.086    0.50 (0.33--0.74)    0.001
  Asian               2   0.81 (0.69--0.96)   0.013    0.48 (0.31--0.31)   0.000    1.00 (0.80--1.24)   0.997    0.88 (0.72--1.09)    0.246    0.48 (0.32--0.72)    0.000
  Caucasian           2   0.71 (0.44--1.13)   0.151    1.56 (0.18--13.3)   0.684    0.61 (0.36--1.02)   0.061    0.64 (0.38--1.07)    0.083    1.71 (0.20--14.6)    0.624

**Abbreviations:** H, heterogeneity; OR, odds ratio.
